[PDF][PDF] Committee on the prevention of mental disorders and substance abuse among children, youth, and young adults: Research advances and promising …

ME O'Connell, T Boat… - … mental, emotional, and …, 2009 - mindpeacecincinnati.com
This report calls on the nation—its leaders, its mental health research and service provision
agencies, its schools, its primary care medical systems, its community-based organizations …

NMDAR hypofunction animal models of schizophrenia

G Lee, Y Zhou - Frontiers in molecular neuroscience, 2019 - frontiersin.org
The N-methyl-d-aspartate receptor (NMDAR) hypofunction hypothesis has been proposed to
help understand the etiology and pathophysiology of schizophrenia. This hypothesis was …

Schizophrenia,“just the facts” what we know in 2008. 2. Epidemiology and etiology

R Tandon, MS Keshavan, HA Nasrallah - Schizophrenia research, 2008 - Elsevier
Although we have studied schizophrenia as a major disease entity over the past century, its
causes and pathogenesis remain obscure. In this article, we critically review genetic and …

[图书][B] Preventing mental, emotional, and behavioral disorders among young people: Progress and possibilities

National Research Council - 2009 - nap.nationalacademies.org
Preventing Mental, Emotional, and Behavioral Disorders Among Young People: Progress and
Possibilities | The National Academies Press Skip to main content Navigate to Help Ordering …

Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects

M van den Buuse - Schizophrenia bulletin, 2010 - academic.oup.com
In recent years, there have been huge advances in the use of genetically modified mice to
study pathophysiological mechanisms involved in schizophrenia. This has allowed rapid …

Models of schizophrenia in humans and animals based on inhibition of NMDA receptors

V Bubeníková-Valešová, J Horáček, M Vrajová… - Neuroscience & …, 2008 - Elsevier
The research of the glutamatergic system in schizophrenia has advanced with the use of
non-competitive antagonists of glutamate NMDA receptors (phencyclidine, ketamine, and …

Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons

L Wen, YS Lu, XH Zhu, XM Li… - Proceedings of the …, 2010 - National Acad Sciences
Neuregulin 1 (NRG1) is a trophic factor thought to play a role in neural development. Recent
studies suggest that it may regulate neurotransmission, mechanisms of which remain …

Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia

JW Young, SB Powell, V Risbrough, HM Marston… - Pharmacology & …, 2009 - Elsevier
Cognitive deficits in schizophrenia are among the core symptoms of the disease, correlate
with functional outcome, and are not well treated with current antipsychotic therapies. In …

A review of the fetal brain cytokine imbalance hypothesis of schizophrenia

U Meyer, J Feldon, BK Yee - Schizophrenia bulletin, 2009 - academic.oup.com
Maternal infection during pregnancy increases the risk of schizophrenia and other brain
disorders of neurodevelopmental origin in the offspring. A multitude of infectious agents …

Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders

PJ Harrison, EM Tunbridge - Neuropsychopharmacology, 2008 - nature.com
Sex differences in the genetic epidemiology and clinical features of psychiatric disorders are
well recognized, but the individual genes contributing to these effects have rarely been …